Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
NCT Number: NCT04537312
This is a pilot study to determine safety, efficacy, and potential risks of robot assisted nipple sparing mastectomy (RNSM), by utilizing the daVinci surgical system.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Columbus, Ohio, 43210, United States
With the advances of breast reconstruction after mastectomy for the treatment of breast diseases including breast cancer, surgical techniques have evolved to preserve the skin flaps and nipple areolar complex (NAC) to give better aesthetic outcome without compromising outcome. Mastectomy that preserves the NAC is called nipple sparing mastectomy (NSM). NSM can provide major psychosocial benefits for patients but is technically demanding and challenging to perform. Total mammary glandular excision in NSM can be technically challenging due to small size of the incision and poor visualization of dissection plane. Recent studies demonstrate feasibility and safety of performing minimally invasive robot-assisted NSM (RNSM). The technique of RNSM is still novel.
This is a single-arm pilot study for feasibility and safety of RNSM.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Under RNSM
ancillary correlative
Robot-assisted Nipple Sparing Mastectomy
Time frame: Up to 1 year
Measure number of patients who had breast removed en bloc through RNSM incision.
Time frame: Up to 1 year
Number of patients with bleeding requiring re-operation after RNSM.
Time frame: Up to 1 year
Number of patients with infection after surgery requiring antibiotics or re-operation.
Time frame: Up to 1 year
Number of patients with mastectomy flap or nipple-areolar complex necrosis as measured using the SKIN flap score after surgery. Score of A1 indicates normal skin, D4 indicates total full thickness necrosis.
Time frame: Up to 1 year
Investigate the total duration of the operation (surgical time data),
Time frame: Up to 1 year
Investigate the total duration of the operation (surgical time data) of each patient
Time frame: Up to 1 year
Investigate the length of hospitalization for each patient
Time frame: Up to 1 year
Surgery Task Load Index (SURG-TLX) survey from each surgeon performing surgery.
Time frame: Up to 1 year
Musculo-Skeletal Questionnaire (NMSQ) from each surgeon performing surgery.
Time frame: Up to 1 year
Monofilament testing to test for sensation recovery after surgery from each participant. Semmes Weinstein monofilament exam; sensation to series of monofilament with different thickness, compare sensation to preoperative exam.
Time frame: Up to 1 year
Patient satisfaction with the breast after surgery measured by BREAST-Q survey. Lowest score = 0, highest = 100 with higher scores indicating better outcomes / quality of life.
Ohio State University Comprehensive Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02918474
Adenocarcinoma, Anatomic Stage I Breast Cancer AJCC v8
Houston, Texas, United States
View Trial DetailsNCT05012176
Adenocarcinoma, Anatomic Stage 0 Breast Cancer AJCC v8
Columbus, Ohio, United States
View Trial DetailsNCT07259304
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT04001829
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
Birmingham, Alabama, United States
View Trial Details